Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1992-7-2
pubmed:abstractText
In an attempt to identify the phenotype of the CD25+ cells previously demonstrated in late-phase allergic reactions in skin and nasal mucosa, and in the bronchial mucosa in atopic asthma we have investigated the co-expression of CD3 and CD25 using double immunofluorescent staining. Fluorescein isothiocyanate (FITC) conjugated anti-CD3 monoclonal antibody and a biotinylated anti-CD25 monoclonal antibody (which was later developed with Texas Red streptavidin) were applied simultaneously to cryostat sections or cytospins of freshly prepared samples. Skin and nasal biopsies were from antigen-induced late-phase reactions, and bronchial biopsies and cytospins of bronchoalveolar lavage cells were from subjects with moderate atopic asthma. Four to 14% of CD3+ cells in these tissues were CD25+ and 61-100% of CD25+ cells also expressed CD3. However, CD25 was also expressed on non-CD3+ cells, assumed to be non-T cells. These results were comparable to that observed with a positive control of a tuberculin-challenged skin biopsy. Thus the majority of cells expressing CD25 in various types of atopic allergic inflammation in man were T lymphocytes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-1673877, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-1777835, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-1830598, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-1885772, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-1918731, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-1997656, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2022726, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2101599, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2252260, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2690708, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2783333, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2826636, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2896958, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2967330, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-2974055, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-3118989, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-6408171, http://linkedlifedata.com/resource/pubmed/commentcorrection/1534311-77279
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0019-2805
pubmed:author
pubmed:issnType
Print
pubmed:volume
75
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
659-63
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Co-expression of CD25 and CD3 in atopic allergy and asthma.
pubmed:affiliation
Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, U.K.
pubmed:publicationType
Journal Article